NEWS ABOUT US EXPERIENCE STRATEGY TEAM PORTFOLIO CONTACT US

 

NEWS

2013 |2012 | 2011 | 2010 | 2009

 

 

 


Nanosys
March 16, 2017 - NANOSYS AND EXCITON TECHNOLOGY PARTNER TO ACCELERATE ADOPTION OF QUANTUM DOT TECHNOLOGY FOR DISPLAYS IN CHINA
Press Release | Company News


Insmed
Febuary 23, 2017 - Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update
Press Release | Company News


Insmed
Febuary 14, 2017 - Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent
Press Release | Company News


Nanosys
January 3, 2017- DSCC RELEASES FREE WHITE PAPER: ON OLEDS OR QUANTUM DOTS, WHICH TECHNOLOGY WILL DOMINATE THE TV MARKET OF THE FUTURE – OLEDS OR QUANTUM DOTS?
Press Release | Company News


NinePoint
November 15, 2016 - NinePoint Medical Announces Substantial Hospital Reimbursement Increase for Procedures Using the NvisionVLE® Imaging System with Real-time Targeting™
Press Release | Company News


Insmed
November 14, 2016 - Insmed to Participate at November Investor Conferences
Press Release | Company News


Insmed
November 3, 2016 - Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update
Press Release | Company News


Insmed
October 18, 2016 - Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
Press Release | Company News


NinePoint
October 15, 2016 - New Clinical Data using the NvisionVLE® Imaging System to be presented at ACG 2016 and UEGW 2016
Press Release | Company News


Insmed
October 5, 2016 - Insmed Appoints Roger Adsett as Chief Commercial Officer
Press Release | Company News


SentreHeart
September 27, 2016 - SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial
Press Release | Company News


Insmed
September 27, 2016 - Insmed Appoints Roger Adsett as Chief Commercial Officer
Press Release | Company News


Nanosys
September 8, 2016 - IFA's "Quantum Dot Technology Gold Award" was awarded to TCL for its new Xclusive X1 QUHD quantum dot TV, the "Q65X1S-CUD".
Press Release | Company News


Vitae Pharmaceuticals
September 14, 2016 - Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions
Press Release | Company News


DFine
July 16, 2016 - Merit Medical Acquires DFINE, Inc.
Press Release | Company News


NinePoint
May 19, 2016 - NinePoint Medical Announces Completion of Clinical Registry and Publication of Results at DDW 2016
Press Release | Company News


NinePoint
May 10, 2016 - NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.
Press Release | Company News


Vitae Pharmaceuticals
March 30, 2016 - Vitae Pharmaceuticals Closes Public Offering of Common Stock
Press Release | Company News


Vitae Pharmaceuticals
March 24, 2016 - Vitae Pharmaceuticals Prices Public Offering of Common Stock
Press Release | Company News


NGM Biopharmaceuticals
January 26, 2016 - NGM Aims For Three Drugs In Clinical Trials, Padded By Cash From Merck
Press Release | Company News


Vitae Pharmaceuticals
December 29, 2015 - Vitae Pharmaceuticals Doses First Patients in Phase 2a Proof-of-Concept Trial of VTP-38543 in Atopic Dermatitis
Press Release | Company News


DFine
December 15, 2015 - DFINE Announces Commercial Launch of the Long SpineSTAR® Ablation Instrument for the Palliative Treatment of Metastatic Spine Tumors
Press Release | Company News


Vitae Pharmaceuticals
December 14, 2015 - Vitae Pharmaceuticals Announces Addition to the NASDAQ Biotechnology Index
Press Release | Company News


Vitae Pharmaceuticals
December 10, 2015 - Vitae Pharmaceuticals Opens Phase 2a Proof-of-Concept Trial of VTP-38543 in Atopic Dermatitis Patients
Press Release | Company News


Vitae Pharmaceuticals
November 18, 2015 - Vitae Pharmaceuticals Announces Positive Top-Line Results From a Phase 1 Multiple Ascending Dose Trial of VTP-43742
Press Release | Company News


SentreHeart
October 12, 2015 - Heart Hospital of Austin First in the United States To Offer Potential New Treatment Alternative To Patients with Atrial Fibrillation
Press Release | Company News


SentreHeart
October 9, 2015 - SentreHEART Receives CE Mark Approval for the LARIAT Surgical Left Atrial Appendage Suture Delivery Device
Press Release | Company News


Kythera
October 1, 2015 - Allergan Successfully Completes Kythera Acquisition; Adds Game-Changing KYBELLA Treatment for Double-Chin
Press Release | Company News


Vitae Pharmaceuticals
September 30, 2015 - Vitae Pharmaceuticals Appoints Dr. Karen Bernstein to Board of Directors
Press Release | Company News


NGM Biopharmaceuticals
September 30, 2015 - NGM Bio is named one of FierceBiotech’s “Fierce 15” Biotech Companies of 2015
Press Release | Company News


Vitae Pharmaceuticals
September 29, 2015 - Vitae Pharmaceuticals Initiates Second Part of a Phase 1 Multiple Ascending Dose Study of VTP-43742 in Psoriatic Patients
Press Release | Company News


Topica Pharmaceuticals
September 16, 2015- Topica Annouces 10% Luliconazole Program Ready for Phase 3 Development for Onychomycosis Based on Positive Phase 2 Results
Press Release | Company News


Vitae Pharmaceuticals
September 8, 2015 - Vitae Pharmaceuticals Announces Positive Top-Line Results From Initial Phase 1 Study of First-in-Class RORyt Inhibitor VTP-43742 in Autoimmune Disorders
Press Release | Company News


SentreHeart
August 24, 2015 - SentreHEART Elects Medical Device Industry Veteran Richard Ferrari to Board of Directors
Press Release | Company News


Vitae Pharmaceuticals
August 10, 2015 - Vitae Pharmaceuticals Announces Initiation of a Phase 1 Multiple Ascending Dose Study of VTP-43742 in Autoimmune Disorders
Press Release | Company News


Vitae Pharmaceuticals
July 29, 2015 - Vitae Pharmaceuticals Appoints Dr. John M. Leonard to Board of Directors
Press Release | Company News

Kythera
July 27, 2015 - KYTHERA Biopharmaceuticals Announces Health Canada Authorization of BELKYRA™, A Submental Contouring Injectable Drug
Press Release | Company News


Nora Therapeutics
July 8, 2015 - Nora Therapeutics Appoints Joseph L. Turner to Board of Directors
Press Release | Company News


SentreHeart
June 25, 2015 - SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial Appendage as Adjunctive Treatment for Atrial Fibrillation
Press Release | Company News


Kythera
June 19, 2015 - KYTHERA Biopharmaceuticals Announces US Availability of KYBELLA(TM) -- First FDA-Approved Injectable Treatment for "Double Chin" -- Through KYBELLA(TM) Trained Physicians
Press Release | Company News


Kythera
June 17, 2015 - Allergan to Acquire KYTHERA Biopharmaceuticals
Press Release | Company News

Nanosys
June 1, 2015 - Samsung Venture Investment Corporation completes follow-on investment in Nanosys
Press Release | Company News


Nanosys
June 1, 2015 - Nanosys First to Achieve EPA Approval for Mass Production of Quantum Dots
Press Release | Company News


Kythera
April 29, 2015 - Biopharmaceuticals Announces FDA Approval of KYBELLA(TM) (also known as ATX-101) -- First and Only Submental Contouring Injectable Drug
Press Release | Company News


Insmed
April 6, 2015 - Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
Press Release | Company News


Kythera
March 10, 2015 - Kythera Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
Press Release | Company News


Novavax
March 10, 2015 - Novavax Appoints Brian Rosen as Vice President, Government Affairs
Press Release | Company News


Kythera
March 9, 2015 - Announces Proposed Public Offering of Common Stock Announces Proposed Public Offering of Common Stock
Press Release | Company News


NGM Biopharmaceuticals
March 3, 2015 - Merck & Co and NGM Biopharmaceuticals team to take on obesity and diabetes
Press Release | Company News


NGM Biopharmaceuticals
March 2, 2015 - NGM Biopharmaceuticals Announces Expansion of Management Team
Press Release | Company News


Kythera
March 9, 2015 - Kythera Biopharmaceuticals Announces FDA Advisory Committee Unanimously (17-0) Recommends to Approve ATX-101 (deoxycholic acid) Injection to Improve the Appearance of Moderate to Severe Submental Fullness
Press Release | Company News


NGM Biopharmaceuticals
February 23, 2015 - NGM and Merck Announce Broad Strategic Collaboration to Discover, Develop and Commercialize Novel Biologic Therapeutics
Press Release | Company News


NGM Biopharmaceuticals
February 23, 2015 - Merck Bets $450M On 'Old School' Biotech From NGM
Press Release | Company News


Kytheraz
February 9, 2015 - Kythera Acquires Worldwide Rights to Clinical Compound and Key Intellectual Property for Potential Novel Treatment of Hair Loss
Press Release | Company News


Kythera
February 4, 2015 - Kythera Biopharmaceuticals Submits Drug Application in Australia for Novel Submental Contouring Injectable Drug ATX-101
Press Release | Company News


Vitae Pharmaceuticals
January 28, 2015 - Vitae Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Follow-on Public Offering of Common Stock
Press Release | Company News


Vitae Pharmaceuticals
January 23, 2015 - Vitae Pharmaceuticals Announces Pricing of Follow-on Public Offering of Common Stock
Press Release | Company News


Vitae Pharmaceuticals
January 20, 2015 - Vitae Pharmaceuticals Launches Proposed Follow-on Public Offering of Common Stock
Press Release | Company News


Vitae Pharmaceuticals
Decemeber 23, 2014 - Vitae Pharmaceuticals Added to Russell 2000(R) and Russell 3000(R) Indexes
Press Release | Company News


Vitae Pharmaceuticals
Decemeber 8, 2014 - Vitae Pharmaceuticals Among 2014 Best Places to Work in PA
Press Release | Company News


NinePoint
Decemeber 4, 2014 - NinePoint Medical Appoints Christopher von Jako, Ph.D., to Chief Executive Officer
Press Release | Company News


Novavax
November 20 2014 - U.S. FDA Grants Fast Track Designation to Novavax’ RSV F-Protein Nanoparticle Vaccine for Protection of Infants via Maternal Immunization
Press Release | Company News


Novavax
November 17, 2014 - Novavax Initiates Phase 2 Clinical Trial of Quadrivalent Seasonal Influenza VLP
Press Release | Company News


Novavax
November 10, 2014 - Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects
Press Release | Company News


Novavax
October 29, 2014 - U.S. FDA Grants Fast Track Designation to Novavax' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M(TM)
Press Release | Company News


Novavax
October 27, 2014 - Novavax Announces Ebola Vaccine Development Program at the 8th Vaccine and ISV Conference in Philadelphia
Press Release | Company News


Vitae Pharmaceuticals
October 27, 2014 - Vitae Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares of Initial Public Offering
Press Release | Company News


Novavax
October 26, 2014 - Novavax Presents RSV F Protein Nanoparticle Vaccine Clinical Data at the 8th Vaccine & ISV Congress
Press Release | Company News


Vitae Pharmaceuticals
October 23, 2014 - Positive Top-Line Results Achieved From Two Phase 1 Clinical Trials of BACE Inhibitor BI1181181/VTP-37948 in Alzheimer's Disease
Press Release | Company News


Novavax
September 24, 2014 - Analyst Day Highlights Vaccine Programs; Increasing Pricing Target to $10.5
Press Release | Company News


Vitae Pharmaceuticals
September 24, 2014 - Vitae Pharmaceuticals Announces Pricing of Initial Public Offering
Press Release | Company News


Novavax
Septmber 23, 2014 - Novavax’ H7N9 Avian Influenza VLP Vaccine Candidate with Matrix-M™ Delivers Positive Phase 1/2 Clinical Data
Press Release | Company News


Novavax
September 23, 2014 - Novavax Announces BARDA Exercise of Contract Option
Press Release | Company News


Nora Therapeutics
September 16, 2014 - Nora Names Sandra Shpilberg Vice President, Strategic Marketing & Commercial Planning
Press Release | Company News


Novavax
September 16, 2014 - Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women
Press Release | Company News


Nora Therapeutics
August 25, 2014 - Nora Named Team RESOLVE Partner by RESOLVE: The National Infertility Association
Press Release | Company News


DFine
July 21, 2014 - Multi-center trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment
Press Release | Company News


Kythera
July 10, 2014 - Kythera Announces FDA Acceptance of ATX-101 New Drug Application
Press Release | Company News


Baxano Surgical
June 30, 2014 - Baxano Surgical Announces First Clinical Use of the Avance MIS Pedicle Screw System
Press Release | Company News


Amicus Therapeutics
June 30, 2014 - Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012
Press Release | Company News


Nora Therapeutics
June 26, 2014 - Nora Therapeutics Announces Initiation of Phase 2 RESPONSE Research Study
Press Release | Company News


DFine
June 11, 2014 - DFinennounces Commencement of Clinical Study of Spinal Tumor Ablation with the Star Tumor Ablation System
Press Release | Company News


Novavax
June 11, 2014 - Novavax Announces Exercise of Option to Purchase Additional Shares and Closing of Public Offering
Press Release | Company News


Novavax
June 5, 2014 - Novavax Prices Public Offering of Common Stock
Press Release | Company News


Novavax
June 4, 2014 - Novavax Announces Proposed Public Offering of Common Stock
Press Release | Company News


Nora Therapeutics
April 17, 2014 - Nora Therapeutics Announces $18 Million Series B Financing
Press Release | Company News


Portola Pharmaceuticals
March 27, 2014 - Portola Pharmaceuticals Initiates Phase 2 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, and Factor Xa Inhibitor Edoxaban
Press Release | Company News


Insmed
March 26, 2014 - Insmed Announces Results from Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacterial Lung Infections
Press Release | Company News


Cabochon
March 21, 2014 - Ulthera, Inc. Plans to Enter Cellulite Market with Acquisition of Cabochon Aesthetics, Inc.
Press Release | Company News


NinePoint
March 20, 2014 - NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE™ Imaging System
Press Release | Company News


Baxano Surgical
March 11, 2014 - Baxano Surgical, Inc. Announces $10 Million Private Placement of Convertible Debentures
Press Release | Company News


Kythera
March 10, 2014 - Kythera Acquires Rights to ATX-101 Outside of the US and Canada from Bayer Consumer Care
Press Release | Company News


Novavax
March 10, 2014 - Novavax Reports Fourth-Quarter and Year-End 2013 Financial Results and Initiation of Phase 1/2 Clinical Trial of Its H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M
Press Release | Company News


Novavax
March 10, 2014 - Novavax Appoints John J. Trizzino as Senior Vice President, Commercial Operations
Press Release | Company News


Amicus Therapeutics
March 3, 2014 - Amicus Therapeutics Appoints Jay A. Barth, MD as Chief Medical Officer and Promotes Bradley L. Campbell to Chief Operating Officer
Press Release | Company News


Novavax
February 27, 2014 - Novavax Announces Extension of Contract for Advanced Development of Recombinant Influenza Products and Pandemic Preparedness with HHS-BARDA
Press Release | Company News


Vitae Pharmaceuticals
February 20, 2014 - Vitae Pharmaceuticals Earns $14 Million Milestone Payment from Boehringer Ingelheim in Alzheimer’s Collaboration
Press Release | Company News


Insmed
February 19, 2014 - Insmed Provides Interim Update from Two-Year, Open-Label Extension Study of ARIKACE to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients
Press Release | Company News


DFine
February 18, 2014 - New studies highlight benefits of Start Tumor Ablation System for Patients with Spinal Tumors
Press Release | Company News


Novavax
February 11, 2014 - Hansen Medical Announces FDA Clearance of the Magellan™ 6Fr Robotic Catheter
Press Release | Company News


Insmed
February 10, 2014 - Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication
Press Release | Company News


Portola Pharmaceuticals
February 3, 2014 - Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement With Bayer and Janssen for Phase 3 Studies of Andexanet Alfa*, Investigational Factor Xa Inhibitor Reversal Agent, and XARELTO(R)
Press Release | Company News


Hansen Medical
January 20, 2014 - Hansen Medical's Magellan(TM) Robotic System to Be Featured in Three Live Cases at 26th Annual International Symposium on Endovascular Therapy
Press Release | Company News


Novavax
January 13, 2014 - Novavax Announces Continuation of RSV Vaccine Partnership with PATH
Press Release | Company News


Portola Pharmaceuticals
January 13, 2014 - Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis
Press Release | Company News

 

 

News Archives